SCHEMBL5326485

SCHEMBL5326485

O=C(c1ccc(-c2ccc(=O)[nH]n2)cc1)N1CCN(S(=O)(=O)c2ccc3c(Cl)n[nH]c3c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
MAPT P10636 3/20 0.47
LMNA P02545 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
USP2 O75604 1/20 0.43
GAA P10253 1/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
THRB P10828 1/20 0.43
ABL1 P00519 4/20 0.43
BCR P11274 4/20 0.43
F10 P00742 1/20 0.42
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5327745 0.89 MAPT (0.52) ALDH1A1L3MBTL1MAPTLMNAMEN1
SCHEMBL5323222 0.89 L3MBTL1 (0.47) ALDH1A1L3MBTL1MAPTLMNAMEN1
SCHEMBL6152346 0.84 ALDH1A1 (0.59) ALDH1A1L3MBTL1MAPTF10ATM
SCHEMBL5326524 0.84 L3MBTL1 (0.54) ALDH1A1L3MBTL1MAPTLMNAMEN1
SCHEMBL5322343 0.83 ALDH1A1 (0.53) ALDH1A1L3MBTL1MAPTLMNAMEN1
SCHEMBL6152664 0.80 F10 (0.65) ALDH1A1L3MBTL1MAPTLMNATHRB
SCHEMBL4900354 0.76 F10 (0.65) F10
SCHEMBL14095701 0.75 F10 (0.50) ALDH1A1L3MBTL1MAPTLMNAMEN1
SCHEMBL5327658 0.73 L3MBTL1 (0.42) ALDH1A1L3MBTL1MAPTLMNAMEN1
SCHEMBL5296078 0.73 HRH3 (0.52) L3MBTL1MAPTMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007008145-A1 HETEROCYCLIC SULFONAMIDE DERIVATIVES AS INHIBITORS OF FACTOR XA ASTRAZENECA AB (SE) 2007-01-18 WO claimed
WO-2007008145-A1 HETEROCYCLIC SULFONAMIDE DERIVATIVES AS INHIBITORS OF FACTOR XA ASTRAZENECA AB (SE) 2007-01-18 WO disclosed